 |
At the March 7 NCI All-Hands meeting, Director Dr. Andrew C. von Eschenbach announced the establishment of the John P. Hartinger Executive Leadership Development Award, a scholarship that will be competitively awarded each year to an NCI employee who demonstrates leadership potential, a commitment to public service, and a desire to further his or her executive development. The award honors John Hartinger, associate director for Budget and Financial Management, who has served NCI for 38 years, mostly in the areas of budget and financial management. In addition to his many technical skills, which are widely known and admired across NIH, he has served as a role model, mentor, and teacher for many NCI staff. Six NCI employees received NCI Director Gold Star Awards in recognition of special accomplishments. The awardees are: Dr. Christine Berg, Division of Cancer Prevention; Donna Bonner, Publications Support Branch; Christina Bruce, Office of Workforce Development; Dr. Steve Libutti, Center for Cancer Research; Dr. Linda Weiss, Cancer Centers Branch; and Dr. Jonathan Wiest, Center for Cancer Research. CCCT Staff Appointed Dr. Prindiville received her M.D. from Northwestern University and her M.P.H. from Johns Hopkins University. Following her residency training, she joined NCI as a program director in the Community Clinical Oncology Program. In 1996, she joined the faculty of the University of Colorado Health Sciences Center. She returned to NCI in 2002 and joined the CCR Genetics Branch where she directed the Clinical Cancer Genetics Program at the National Naval Medical Center Breast Care Center and served as a clinical investigator in NCI's Clinical Genetics Branch. Prior to coming to NCI, Dr. Jaffe worked at a biotechnology firm directing a clinical evaluations lab where she was involved in getting FDA approval for a DNA-based diagnostic test for HER-2/neu. Dr. Jensen managed extramural clinical trials in bone marrow transplantation for NHLBI for 10 years before coming to NCI in 2003 to oversee the grants and contracts that support the early drug development program. Dr. Petryshyn, a biochemist and molecular biologist, previously served in NCI's Division of Extramural Activities' Resources Training and Review Branch, and was involved in the review of NCI's Cancer Centers. CCCT will manage the implementation of all Clinical Trials Working Group initiatives. Additional information is available online at http://integratedtrials.nci.nih.gov/ict/. Tucker Named Director of Human Genetics Program
HIV/AIDS Awareness Day Observed |
| U.S. National Institutes of Health | www.cancer.gov |
 | ||||
|
Dr. Tucker received her M.D. from Harvard Medical School and completed her training in internal medicine and medical oncology at Stanford University. Since joining the NCI staff in 1978, she has focused on family and population-based studies of melanoma and other cancers in efforts to identify susceptibility genes and gene-environment interactions. Dr. Tucker was named chief of the Family Studies Section in 1987, became chief of GEB in 1992, and will continue to serve in that capacity. In her new role, she will share responsibility with the division director in managing and strengthening DCEG's intramural and collaborative research programs in cancer genetics.